United States · FDA National Drug Code directory
Chlorothiazide sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68083-614_e19fe503-9b2e-4db0-b4ee-0fb9ec9c11c2
- Product NDC
- 68083-614
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Chlorothiazide sodium
- Labeler
- Gland Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241003
- Source listing expiry
- 20261231
Source-listed ingredients
- CHLOROTHIAZIDE SODIUM — 500 mg/18mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (68083-614-01) / 18 mL in 1 VIAL · 68083-614-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →